These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 8513428

  • 1. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS, Koenig-Berard E, Van Gilst WH.
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    Schölkens BA, Linz W.
    Clin Physiol Biochem; 1990 May; 8 Suppl 1():33-43. PubMed ID: 2147878
    [Abstract] [Full Text] [Related]

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 4. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C, Cosentino E, De Sanctis D.
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. [Action of converting enzyme inhibitors on myocardial ischemia and reperfusion injuries].
    Galinier M, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():99-104. PubMed ID: 8304819
    [Abstract] [Full Text] [Related]

  • 7. [Prevention with angiotensin-converting enzyme (ACE) inhibitors].
    Ertl G, Gaudron P, Neubauer S, Bauer B.
    Z Kardiol; 1992 Jul; 81 Suppl 4():205-10. PubMed ID: 1290300
    [Abstract] [Full Text] [Related]

  • 8. Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
    Dai W, Kloner RA.
    Postgrad Med; 2011 Mar; 123(2):49-55. PubMed ID: 21474893
    [Abstract] [Full Text] [Related]

  • 9. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO.
    J Cardiovasc Pharmacol; 1987 Mar; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C, Mastrorilli F, Squasi PA, Gaitani S, Guardigli G, Ferrari R.
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [Abstract] [Full Text] [Related]

  • 11. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
    Anderson B, Khaper N, Dhalla AK, Singal PK.
    Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
    [Abstract] [Full Text] [Related]

  • 12. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M, Solomon SD.
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [Abstract] [Full Text] [Related]

  • 13. Effect of ACE inhibition on neurohormones.
    Remme WJ.
    Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
    [Abstract] [Full Text] [Related]

  • 14. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD.
    J Cardiovasc Pharmacol; 1994 Sep; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A, Talreja A, Sonnenblick EH, LeJemtel TH.
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ, Gums JG.
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [Abstract] [Full Text] [Related]

  • 18. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A, Teo KK.
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [Abstract] [Full Text] [Related]

  • 19. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H, Mohuczy D, Li D, Kimura B, Phillips MI, Mehta P, Mehta JL.
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.